Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 26, 2021

SELL
$232.72 - $256.47 $592,737 - $653,229
-2,547 Closed
0 $0
Q2 2021

Jul 26, 2021

BUY
$232.65 - $254.58 $2,093 - $2,291
9 Added 0.35%
2,547 $619,000
Q1 2020

May 07, 2020

SELL
$195.69 - $279.01 $97,845 - $139,505
-500 Reduced 16.46%
2,538 $583,000
Q4 2019

Feb 04, 2020

BUY
$236.45 - $266.82 $8,985 - $10,139
38 Added 1.27%
3,038 $826,000
Q3 2019

Nov 01, 2019

SELL
$230.58 - $256.08 $691,740 - $768,240
-3,000 Reduced 50.0%
3,000 $759,000
Q3 2018

Nov 01, 2018

SELL
$233.07 - $256.0 $3,496 - $3,840
-15 Reduced 0.25%
6,000 $1.57 Million
Q2 2018

Jul 26, 2018

BUY
$208.1 - $233.85 $3,121 - $3,507
15 Added 0.25%
6,015 $1.44 Million
Q3 2017

Nov 01, 2017

BUY
$186.89 - $198.9 $1.12 Million - $1.19 Million
6,000
6,000 $1.18 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Klingenstein Fields & CO LP Portfolio

Follow Klingenstein Fields & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingenstein Fields & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Klingenstein Fields & CO LP with notifications on news.